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Background: Gene expression patterns are determined by rates of mRNA transcription and decay. While transcription
is known to regulate many developmental processes, the role of mRNA decay is less extensively defined. A critical step
toward defining the role of mRNA decay in neural development is to measure genome-wide mRNA decay rates in
neural tissue. Such information should reveal the degree to which mRNA decay contributes to differential gene
expression and provide a foundation for identifying regulatory mechanisms that affect neural mRNA decay.
Results: We developed a technique that allows genome-wide mRNA decay measurements in intact Drosophila
embryos, across all tissues and specifically in the nervous system. Our approach revealed neural-specific decay kinetics,
including stabilization of transcripts encoding regulators of axonogenesis and destabilization of transcripts encoding
ribosomal proteins and histones. We also identified correlations between mRNA stability and physiologic properties of
mRNAs; mRNAs that are predicted to be translated within axon growth cones or dendrites have long half-lives
while mRNAs encoding transcription factors that regulate neurogenesis have short half-lives. A search for candidate
cis-regulatory elements identified enrichment of the Pumilio recognition element (PRE) in mRNAs encoding regulators
of neurogenesis. We found that decreased expression of the RNA-binding protein Pumilio stabilized predicted neural
mRNA targets and that a PRE is necessary to trigger reporter-transcript decay in the nervous system.
Conclusions: We found that differential mRNA decay contributes to the relative abundance of transcripts involved in
cell-fate decisions, axonogenesis, and other critical events during Drosophila neural development. Neural-specific decay
kinetics and the functional specificity of mRNA decay suggest the existence of a dynamic neurodevelopmental
mRNA decay network. We found that Pumilio is one component of this network, revealing a novel function for
this RNA-binding protein.
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Transcription regulates neural developmental processes
ranging from cell-fate specification [1] to synapse forma-
tion [2]. However, differential transcription alone is an
ineffective method of regulating gene expression; math-
ematical models demonstrate that mRNA decay is essen-
tial for precise temporal and spatial control of mRNA
abundance, particularly during developmental transitions
[3]. Multiple mechanisms determine mRNA half-life [4].
One common mechanism involves the recognition of
cis-elements by RNA-binding proteins (RBPs). RBP-
mRNA interactions can activate or inhibit mRNA decay* Correspondence: mcleary4@ucmerced.edu
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ation complexes. Additional mRNA decay mechanisms
include targeting by microRNAs and the nonsense-
mediated decay (NMD) pathway. The stability of an in-
dividual transcript may differ depending on cell type or
the activation of signaling pathways. These mechanisms
establish mRNA decay networks in which mRNA sta-
bility is genetically programmed, tunable, and tightly
regulated.
Regulation of mRNA decay appears to be particularly
important for nervous system development [5]. This is
partly due to the unique architecture of neurons;
mRNAs exit the nucleus far from axon growth cones
and dendrites where some transcripts are translated.
The local concentrations of many mRNAs involved in
axon pathfinding and synapse function are controlledThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Robo3.2 mRNA is degraded by the NMD pathway when
axons encounter the spinal cord floor plate [6]. This
compartmentalized degradation of Robo3.2 is necessary
for the proper decussation of neurons in the spinal cord.
Regulation of mRNA decay is also important for the
proper proliferation and differentiation of neural progen-
itors. Mouse neural progenitors lacking the RBP HuD
have increased rates of self-renewal [7], and a circuitry
involving the NMD pathway and neural miRNAs con-
trols the balance between stem-cell proliferation and
neural differentiation [8]. A role for mRNA decay in
regulating cell-fate specification has been identified for
the glial cells missing (gcm) gene in Drosophila [9].
Expression of a gcm transgene lacking a destabilizing cis-
element causes neural progenitors to produce excess
glia. Numerous examples of microRNAs, nonsense-
mediated decay, and RBPs regulating the decay of target
transcripts during neural development have been de-
scribed, but the degree to which differential mRNA
decay globally affects mRNA abundance during in vivo
neurogenesis is not completely defined.
The degradation of maternally deposited mRNAs in
early Drosophila embryos has provided valuable infor-
mation about the role of mRNA decay in animal devel-
opment [10]. However, analysis of zygotic mRNA decay
during later stages of Drosophila development, specific-
ally in the nervous system, presents several technical
challenges. First, it requires a method to measure mRNA
decay that does not interfere with gene expression or de-
velopment. Traditional approaches for measuring mRNA
decay rely on transcription inhibition (using drugs or
temperature-sensitive mutations that inhibit RNA poly-
merase II) and may have unwanted side effects [11]. Sec-
ond, it requires a method to measure neural-specific
mRNA decay in intact embryos. Many genes with neural
development functions are expressed in multiple tissues,
and the same transcript may have different half-lives in
neural versus non-neural cells. Whole embryo mRNA
decay measurements will therefore represent the aggre-
gate half-life of an mRNA across multiple tissues.
A potential solution to the above mentioned chal-
lenges is to use a pulse-chase approach to ‘tag’ nascent
mRNAs in specific cell types then follow the decay of
tagged mRNAs over time. Tissue-specific expression of
the Toxoplasma gondii uracil phosphoribosyltransferase
(T.g.UPRT) enzyme in Drosophila allows tagging of
nascent mRNAs with 4-thiouracil and subsequent
purification of the tagged mRNA (a technique known
as TU-tagging) [12]. Variations of TU-tagging, in which
pulse-labeling is followed by a “chase” in media lacking
tagged uracil, have been used to obtain genome-wide
mRNA decay measurements in yeast [13] and mammalian
cell lines [14]. Here we combined TU-tagging with apulse-chase approach to obtain genome-wide measure-
ments of mRNA decay across all tissues of Drosophila
embryos and genome-wide measurements of mRNA
decay specifically in the nervous system. This approach
identified key components of a neural development
mRNA decay network, including the differential decay of
mRNAs within distinct functional classes and the role of
the RBP Pumilio in regulating neural mRNA decay.
Results
TU-decay allows mRNA decay measurements in intact
Drosophila embryos
To measure zygotic mRNA decay in Drosophila embryos,
we developed a pulse-chase approach termed ‘TU-decay’.
We first used the nucleoside 4-thiouridine (4sUd) to tag
mRNAs in all embryonic tissues (independent of
T.g.UPRT). Stage 12 to 15 embryos were incubated in 1
mM 4sUd during a 1-hour ‘pulse’ then transferred to
‘chase’ media containing 10 mM uridine. 4sUd-RNA (TU-
RNA) was purified after the 1-hour pulse, a 1-hour chase,
and a 3-hour chase. A potential limitation of this approach
is continued incorporation of 4sUd during the chase, ei-
ther due to incomplete saturation with uridine or recyc-
ling of 4sUd from degraded transcripts. 4sUd
incorporation during the chase could result in artificially
long half-life calculations. To test for such an effect, we
performed parallel experiments in which the transcription
inhibitor actinomycin D (actD) was included in the chase
media. Efficient transcription arrest upon actD exposure
was confirmed by the lack of 4sUd incorporation in actD-
treated embryos (Additional file 1).
TU-RNA abundance at each time point was measured
by microarray analysis, and mRNA half-life was calcu-
lated by fitting measurements to a single exponential
decay equation. Data for the majority of mRNAs fit this
model; 79% of mRNAs from the uridine-only data (UO),
and 87% of mRNAs from the uridine plus actD data
(U + actD) fit with R2 ≥ 0.75. The UO and U + actD
data were first used to test for potential biases in
decay measurements. We did not detect any correl-
ation between uridine number and mRNA half-life
(Additional file 2), demonstrating that uridine frequency
does not affect decay measurements. We also found no
correlation between transcript abundance and mRNA
half-life, demonstrating that there is no bias in the decay
measurements for low-abundance versus high-abundance
transcripts (Additional file 2).
The distribution of mRNA half-lives was similar for
pulse-chase experiments performed with or without
actD (Figure 1A), and decay kinetics for the majority of
mRNAs were highly reproducible; only 11.6% of mRNAs
had standard deviations in half-life ≥30% of the mean
for that transcript. Many transcripts gave nearly identical
results with or without actD in the chase media
Figure 1 TU-decay measures genome-wide mRNA half-lives without transcription arrest. (A) Distribution of whole embryo mRNA half-lives based
on uridine chase conditions (Uridine only) and uridine chase combined with actinomycin D to arrest transcription (Uridine + ActD). t1/2 = half-life.
(B) Individual transcript decay curves based on the uridine-only and uridine + actD measurements. Chase times are plotted on the x-axis (0-hour = end
of 1-hour pulse). Mean chase/pulse values are plotted at the 1-hour and 3-hour time points, and curves were fit using a single-order exponential decay
equation. Error bars are standard deviation.
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high-stability mRNAs (for example, eIF4a [15]) and low-
stability mRNAs (for example, Myc [16]). An additional
indication of the reproducibility of these measurements
is provided by gene ontology (GO) analysis of the UO
and U + actD datasets. The top 1,000 most stable
transcripts and the bottom 1,000 least stable transcripts
from both datasets yielded very similar GO results
(Additional file 3). Given the reproducibility and simi-
larity of decay measurements obtained with or without
actD, we conclude that TU-decay effectively measures
mRNA decay without the need to use pharmacological
inhibitors of RNA polymerase II or other methods of
arresting transcription.
Gene ontology categories identified by combining the
UO and U + actD datasets are summarized in Table 1,
and a complete list of half-lives is provided in Additional
file 4. The results are similar to category enrichments
seen for stable versus unstable mRNAs in studies of
Drosophila maternal mRNA decay [10], yeast mRNA
decay [17], and mammalian mRNA decay [18]. High-
stability transcripts had a significant enrichment of
mRNAs encoding ribosomal proteins, cytoskeletal pro-
teins, chromatin-associated proteins, electron transport
proteins, and other mRNAs involved in constitutive or
‘housekeeping’ functions. Low-stability transcripts had a
significant enrichment of mRNAs encoding transcriptionfactors, kinases, and other mRNAs associated with cell-
fate decisions and organ development, including regula-
tors of neuron projection morphogenesis. This agreement
with gene ontology results obtained using alternative
model systems further supports the validity of our pulse-
chase approach. We conclude that TU-decay is an effective
technique for measuring mRNA decay in Drosophila
embryos.
TU-tagging purifies neural-transcribed mRNAs from whole
embryos
We previously used TU-tagging to identify taranis as a
nervous system-expressed gene in Drosophila embryos
[19]. These experiments used prospero-GAL4 to drive
UAS-T.g.UPRT expression (pros > UPRT). Embryos at 0
to 16 h of development were exposed to 4-thiouracil
(4TU) for 2 h and TU-tagged RNA was isolated from
whole embryo lysates. Purified TU-RNA was compared
to non-tagged RNA from the same embryos in micro-
array experiments. The prospero-GAL4 construct ex-
presses GAL4 in neuroblasts, ganglion mother cells, and
glia of the central nervous system (CNS) (Figure 2A) in
addition to peripheral sensory neurons. Prospero-Gal4
driving UAS-T.g.UPRT also results in mRNA tagging in
post-mitotic CNS neurons since the UPRT (and likely
some converted 4-thio-UMP) is transferred from pro-
genitors to neurons [20].
Table 1 Whole embryo mRNA decay analysis: functional annotation of high-stability and low-stability mRNAs
Whole embryo measurements: high-stability mRNAs
GO term Definition P value FDR Count Fold enrichment
0022626 Cytosolic ribosome 2 × 10−57 5 × 10−56 67 10.3
RpL4, RpL23, RpS16, RpS24
0000022 Microtubule cytoskeleton 8 × 10−17 3 × 10−14 57 3.5
Tub84b, Tub56D, ssp4, robl
0022900 Electron transport chain 1 × 10−14 2 × 10−12 29 5.9
mt:Cyt-b, mt:CoI, mt:CoII, mt:ND1
0031497 Chromatin assembly 2 × 10−9 2 × 10−7 15 7.8
His1, His2A, His2Av, His2B, His3
0045941 Positive regulation of transcription 4 × 10−3 .14 15 2.4
DSIF, HP1, Trl, ash2, lid, arm, btd
0048024 Regulation of mRNA splicing 7 × 10−3 .19 10 2.9
Hrb27c, Hrb87f, B52, SC35, snf
Whole embryo measurements: low-stability mRNAs
GO term Definition P value FDR Count Fold enrichment
0004672 Protein kinase activity 2 × 10−9 1 × 10−6 41 2.6
S6kII, BubR1, mkk4, dTOR, wts, htl
0048812 Neuron projection morphogenesis 2 × 10−8 2 × 10−6 40 2.7
Con, trio, Ephrin, Eph, otk, drl, rl
0006351 Transcription 1 × 10−5 4 × 10−4 47 1.8
svp, dpn, Myc, grn, kn, Trx, eve
0019226 Transmission of nerve impulse 3 × 10−5 9 × 10−4 26 2.6
CASK, cha, synaptogyrin, cpx, shi
0014706 Striated muscle tissue development 3 × 10−5 1 × 10−3 11 5.3
Hem, Mef2, Mlp84B, flw, mbc
0051674 Localization of cell 5 × 10−4 .01 23 2.3
cbl, APC, Dl, Mhc, baz, dome, cv-c
Gene ontology categories enriched among the 500 most stable and 500 least stable transcripts were identified using DAVID. Representative genes are listed for
each category. FDR is the Benjamini-Hochberg false discovery rate.
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ously described) identified 148 genes enriched 1.5-fold or
greater compared to untagged mRNA, including prospero
itself (Additional file 5). Published literature and the
Berkeley Drosophila Genome Project (BDGP) in situ data-
base provided embryonic expression patterns for 108 of
the 148 enriched genes. Of these, 94 (87%) are expressed
in the nervous system. To further test the identification of
neural mRNAs, we performed in situ hybridizations for
ten enriched mRNAs whose expression patterns had not
previously been characterized. We found that all ten were
expressed in the nervous system, with eight specifically
expressed in the CNS (Figure 2B). In total, we verified
that 104 out of 118 (88%) genes identified by pros > UPRT
TU-tagging were expressed in the nervous system.
We used the same pros > UPRT genotype to perform
nervous system-specific TU-decay analysis. Stage 12 to15 embryos were exposed to the pulse-chase time course
described for whole embryos. To confirm enrichment
of neural mRNAs in these experiments, we compared
the pulse-labeled TU-RNA from pros > UPRT embryos
to the pulse-labeled TU-RNA from whole embryos.
Neural-specific TU-RNA had a modest enrichment of
known nervous system-expressed mRNAs, as expected
given the presence of these transcripts in both stage-
matched samples (Figure 2C). Neural-specific TU-RNA
was significantly depleted of many mRNAs primarily
expressed in the mesoderm and muscle (Figure 2C).
We also performed gene ontology analysis of transcripts
that were absent from neural-specific TU-RNA but
present in whole embryo TU-RNA. This revealed a sig-
nificant depletion of transcripts associated with the de-
velopment or function of tissues outside the nervous
system (Figure 2D). Based on the above indicators of
Figure 2 Pros > UPRT TU-tagging purifies neural mRNAs from embryos. (A) Prospero-GAL4 driving UAS-GFP::lacZ.nls (encoding a nuclear-localized
GFP-β-galactosidase fusion) in the embryonic central nervous system shows the expression pattern of prospero-GAL4. Anti-Prospero =magenta,
anti-β-galactosidase = green. (B) RNA in situ hybridization for eight genes identified as nervous system-enriched by TU-tagging. Gene annotation
symbols are listed in the top panel. Top panel = ventral view. Bottom panel = lateral view. Developmental stage is listed in the lower right corner
of each embryo image. (C) Relative abundance of mesoderm or muscle-specific mRNAs and neural-specific mRNAs in 1-hour pulse-labeled TU-RNA
samples. ** = FDR ≤0.20, * = FDR ≤0.40 based on SAM analysis. (D) Gene ontology categories depleted from neural TU-RNA samples (mRNAs below
detection in the 1-hour pulse pros > UPRT TU-RNA microarrays but present in 1-hour pulse whole embryo TU-RNA microarrays). All categories were
significantly depleted at P values≤ 1.0 × 10−4 based on DAVID analysis.
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pros > UPRT pulse-chase data to calculate neural mRNA
half-lives.
Functionally related mRNAs have neural-specific decay
kinetics
Neural mRNA half-lives were calculated as described for
whole embryos. Seventy-three percent of mRNAs fit the
exponential decay equation with an R2 ≥ 0.75. The repro-
ducibility of neural-specific measurements was similar tothat observed for whole embryos; between biological
replicates, only 13.1% of mRNAs had standard devia-
tions in half-life ≥30% of the mean for that transcript.
The distribution of mRNA half-lives based on neural-
specific and whole embryo measurements was very
similar (Figure 3A). This suggests that the general
mRNA-decay machinery and kinetics of turnover are
not substantially different in the nervous system com-
pared to other tissues. Genome-wide neural-specific
mRNA half-lives are provided in Additional file 6.
Figure 3 Comparison of neural-specific and whole embryo decay measurements suggests many transcripts have neural-specific half-lives.
(A) Distribution of mRNA half-lives in the whole embryo and neural-specific datasets. Only mRNAs with reproducible half-life measurements
across replicates were included in the distribution and mean/median calculations. (B) Comparison of individual mRNA half-lives obtained
by neural-specific versus whole embryo measurements. Spots represent the mean half-life of individual transcripts. Additional mRNAs with
whole embryo half-lives estimated at ≥600 min are listed in Additional file 7. Select mRNAs with half-life differences of ≥1.5-fold are labeled, with
statistical significance indicated by the FDR color code.
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stability neural mRNAs identified several differences
compared to the whole embryo dataset (Table 2). While
both datasets had the category ‘transcription’ enriched
among low-stability mRNAs, the neural-specific mea-
surements had a unique enrichment of mRNAs involved
in neuron differentiation, mitosis, histone methylation,
endocytosis, and ribosome biogenesis. Differences be-
tween the two datasets are even more striking for
high-stability mRNAs. The most significantly enriched
category for neural high-stability mRNAs is ‘neuron pro-
jection morphogenesis’ which includes regulators of axo-
nogenesis and axon pathfinding. In contrast, mRNAs in
this category were among the least stable mRNAs in
whole embryos, suggesting differential regulation of some
transcripts within this GO category. Examples of ‘neuron
projection morphogenesis’ mRNAs with inverse stabili-
ties based on neural-specific versus whole embryo mea-
surements include APC-like, Abelson interacting protein,and off-track. Other high-stability mRNAs unique to the
neural-specific dataset include those encoding small
GTPases that regulate vesicle trafficking and transcripts
encoding regulators of programmed cell death.
Genome-wide comparison of mRNA half-lives be-
tween the neural-specific and whole embryo datasets re-
vealed that 24% of mRNAs had statistically-significant
half-life differences of ≥1.5-fold (484 mRNAs had de-
creased stability based on neural-specific measurements,
and 409 mRNAs had increased stability based on
neural-specific measurements, out of 3,776 transcripts)
(Figure 3B and Additional file 7). Importantly, these
differences do not randomly occur across the transcrip-
tome; mRNAs with different half-lives based on neural-
specific versus whole embryo measurements fall into
specific gene ontology categories (Table 3). mRNAs with
shorter half-lives based on neural-specific measurements
include those encoding ribosomal proteins (26 ribosomal
protein mRNAs), translation regulators (EF2, eIF-5A),
Table 2 Neural-specific mRNA decay analysis: functional annotation of high-stability and low-stability mRNAs
Neural-specific measurements: low-stability mRNAs
GO term Definition P value FDR Count Fold enrichment
0006351 Transcription 4 × 10−10 2 × 10−7 58 2.5
svp, dpn, pros, vvl, grh, gsb, onecut
0030182 Neuron differentiation 2 × 10−7 4 × 10−5 48 2.3
chinmo, Dl, tup, Ephrin, Eph, fax, shot
0007067 Mitosis 6 × 10−5 3 × 10−3 21 2.9
cycB3, cdc27, Sse, cnn, glu, mts
0018024 Histone methyltransferase activity 2 × 10−4 .02 7 6.9
G9a, Set1, Set2, Su(z)12, ash1, egg
0006897 Endocytosis 4 × 10−3 .08 25 1.9
Arpc4, shi, CalpA, pat1, faf, scb, Rac1
0005840 Ribosome 2 × 10−3 .06 21 2.0
RpL17, RpL35, mRpL11, mRpS35
Neural-specific measurements: high-stability mRNAs
GO term Definition P value FDR Count Fold enrichment
0048812 Neuron projection morphogenesis 5 × 10−6 6 × 10−4 33 2.4
trc, fusl, Fas2, Appl, Fmr1, otk, ben
0003924 GTPase activity 2 × 10−4 .02 17 2.9
Rab23, Rab30, Rab11, Rho1, Ras64B
0012501 Programmed cell death 2 × 10−3 .06 17 2.4
grim, pten, scyl, egr, mod(mdg4)
0004672 Protein kinase activity 9 × 10−3 .24 23 1.8
CamKI, Cdk4, Ror, ald, aur, nmo, trbl
0019226 Transmission of nerve impulse .02 .25 17 1.8
CASK, CanB, Dap160, cpx, Sap47
0051674 Localization of cell .01 .16 18 1.9
cbl, APC, cortactin, par-6, baz, spri
Gene ontology categories enriched among the 500 most stable and 500 least stable transcripts were identified using DAVID. Representative genes are listed for
each category. FDR is the Benjamini-Hochberg false discovery rate.
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(Gapdh1, multiple ATP synthetases). mRNAs with longer
half-lives based on neural-specific measurements include
those involved in neurotransmission (CASK, stj, homer,
Dap160, Rop), axonogenesis (pk, Appl, miple, galectin),
axonal transport (Klp64D, TBCB), and establishment or
maintenance of neuroblast polarity (baz, par-6, Lgl, pins,
Gαo). Each of these genes is transcribed in the nervous sys-
tem plus additional tissues (based on FlyBase annotations
and/or BDGP in situ data), suggesting that half-life differ-
ences between whole embryo and neural-specific measure-
ments are due to neural-specific mRNA decay kinetics.
Neural mRNA stability correlates with predicted transcript
localization and function
Gene ontology analysis of neural mRNA-decay data re-
vealed that mRNAs encoding transcription factors tendto be rapidly decayed, and mRNAs encoding proteins in-
volved in neuron projection morphogenesis and neuro-
transmission tend to be stable. The rapid decay of
transcription-factor mRNAs could be related to transient
protein expression during cell-fate specification. To test
this hypothesis, we identified 39 mRNAs encoding tran-
scription factors that are involved in CNS neurogenesis
(based on Interactive Fly annotations [21]). The stability
of mRNAs associated with neuron projection morpho-
genesis and neurotransmission could be related to their
localization in axon growth cones or dendrites. To test
this hypothesis, we identified 35 Drosophila orthologs of
mRNAs that are localized to axon growth cones [22] or
dendrites [23] in mammals.
We compared the half-lives of the neurogenesis
transcription factor mRNAs (which we refer to as
‘neural fate’ mRNAs) and the half-lives of the predicted
Table 3 Functional annotation of mRNAs with altered stability based on neural-specific versus whole embryo measurements
mRNAs stabilized in the nervous system (neural/whole embryo half-life >1.5)
GO term Definition P value FDR Count Fold enrichment
007409 Axonogenesis 2 × 10−3 .06 13 2.8
APC, CadN, trio, caps, fray, otk, daw
0003924 GTPase activity 2 × 10−3 .31 10 3.5
Rab21, Rab30, Ras64B, RabX1
0009312 Oligosaccharide biosynthesis 9 × 10−3 .15 4 9.2
mgat2, GalNAc-T1, pgant2, pgant5
0045196 Establishment of neuroblast polarity .01 .16 3 18.7
par-6, baz, Lgl
0007269 Neurotransmitter secretion .04 .56 6 2.6
CanB, Lgl, CASK, Dap160, cpx, rop
mRNAs destabilized in the nervous system (neural/whole embryo half-life <0.6)
GO term Definition P value FDR Count Fold enrichment
0003735 Structural constituent of ribosome 5 × 10−17 5 × 10−15 26 9.2
RpL11, RpL30, RpL6, RpS16, RpS23
0000278 Mitotic cell cycle 4 × 10−8 4 × 10−5 30 3.2
dap, cycB3, ball, glu, eff, ncd, mts
0031497 Chromatin assembly 3 × 10−4 .02 7 7.5
H2B, H3, H3.3A/B, HP2, Df31, Set
0005839 Proteasome core complex 8 × 10−3 .07 5 6.0
Pros26, Prosα7, Prosβ2, Prosβ7
0006119 Oxidative phosphorylation 6 × 10−4 .03 12 3.5
ATPsynB, ATPsynD, mt:CoIII
Gene ontology categories were identified using DAVID. Representative genes are listed for each category. FDR is the Benjamini-Hochberg false discovery rate.
Burow et al. Neural Development  (2015) 10:11 Page 8 of 16axon or dendrite-localized mRNAs (which we refer to
as ‘localized’ mRNAs) to the half-lives of all neural
mRNAs. This revealed a significant trend of below
average stability for neural fate mRNAs and above
average stability for localized mRNAs (Figure 4A,
Additional file 8). Rapidly decayed neural fate mRNAs
include those encoding proteins whose expression is
tightly coupled to the timing of neuroblast cell divi-
sions (cas, svp, pdm-1) [24]; proteins that are differen-
tially expressed within neuroblast lineages (Hey, Dl) [25];
and proteins that are differentially expressed among neu-
roblasts, GMCs, and neurons (dpn, pros) [26] (Figure 4B).
Thus, rapid mRNA decay correlates with dynamic tem-
poral or spatial patterns of protein expression. Additional
transcription factor mRNAs that are rapidly decayed but
were not included in the list of neurogenesis transcrip-
tion factors include fkh, pnt, glu, BarH1, and others that
may have functions in neural development that require
precise regulation of mRNA abundance.
Stable mRNAs predicted to localize to axon growth
cones or dendrites include a known Drosophila dendrite-
localized mRNA (CamKII [27]) and two orthologs ofmammalian mRNAs that are locally translated in dendrites
(Arc1 [28] and Ef1α100E [29]) (Figure 4C). Stable predicted
localized mRNAs also include transcripts encoding
proteins that localize to pre- or post-synaptic sites in
Drosophila neurons (homer [30], CASK [31], and
synaptogyrin [32]), although the site of translation of
these mRNAs is unknown. We conclude that the ele-
vated stability of these mRNAs may be related to
evolutionarily conserved patterns of subcellular mRNA
localization.
Pumilio regulates neural mRNA decay
To identify sequence elements that might target neural
fate mRNAs for rapid decay, we searched for known cis-
regulatory elements in the 3’ UTRs of this group of
transcripts. As a first step, we tested for any correlation
between 3’ UTR length and mRNA stability, since
shorter 3’ UTRs could contain fewer cis-elements. We
found no correlation between 3’ UTR length and stability
and no bias toward short or long 3’ UTRs in the stable
localized versus unstable neural fate mRNAs (or in the
entire neural mRNA decay dataset) (Additional file 9).
Figure 4 mRNA stability correlates with function and predicted localization. (A) mRNA half-life distributions of all neural mRNAs, the neural fate
transcription factor subset (‘neural fate’), and the predicted axon growth cone or dendrite-localized mRNA subset (‘localized’). The horizontal line
marks the mean neural-specific half-life (76 min). P values are from Mann-Whitney U tests comparing the distribution of half-lives for each subset
to the ‘all mRNAs’ set of transcripts. (B) Representative decay curves for neural fate mRNAs. (C) Representative decay curves for predicted localized
mRNAs. For the graphs in B and C, chase times are plotted on the x-axis (0-hour = end of 1-hour pulse). Mean and standard deviation chase/pulse
values at the 1-hour chase and 3-hour chase time points are plotted based on multiple measurements across biological replicate experiments.
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roles in maternal mRNA decay, known or predicted ex-
pression of the corresponding trans-acting factor in the
nervous system, and the availability of databases that
identify transcripts containing the cis-element. Based on
these criteria, we tested for enrichment or depletion of
AU-rich elements (AREs) [33], miR-124 seed sequences
(miR-124 is a nervous system-specific microRNA [34]),
and Pumilio recognition elements (PREs) [35]. Of these
candidates, only PREs were significantly enriched among
the low-stability neural fate mRNAs (20 out of 36
mRNAs with half-life ≤75 min contain a PRE) and de-
pleted from high-stability localized mRNAs, although
not at a statistically-significant level (1 out of 29 mRNAs
with half-life ≥80 min contain a PRE) (Figure 5A,
Additional file 8). AREs and miR124 seed sequences had
no significant enrichment or depletion in neural fate or
localized mRNAs (Figure 5A) or in the entire set of low
or high-stability neural mRNAs.
For the PRE analysis, we used all mRNAs that contain
the 8-nucleotide motif UGUA(A/U/C)AUA at least
once in their 3’ UTR, as identified by Gerber et al.
[35]. Of the 1,431 mRNAs that contain this motif, 439
were present in our neural-specific dataset. PREs do
not appear to be a general determinant of neuralmRNA stability; there was no significant enrichment
of PRE-containing transcripts among all low-stability
or high-stability neural mRNAs (8.5% of mRNAs with
half-life ≤75 min contain a PRE, and 8.8% of mRNAs
with half-life ≥80 min contain a PRE). In addition to
mRNAs containing the PRE motif, Gerber et al. identi-
fied 156 potential Pumilio targets using a tandem-
affinity purification (TAP)-tagged Pumilio approach
[35]. The list of Pumilio targets identified by TAP does
not include any transcripts from our neural fate or
localized mRNA classes. Similar to the PRE data, the
Pumilio TAP data were not a predictor of mRNA sta-
bility among all neural mRNAs (0.9% of mRNAs with
half-life ≤75 min were predicted targets by TAP, and
1.5% of mRNAs with half-life ≥80 min were predicted
targets by TAP). We conclude that the presence of a
PRE motif (and not identification as a Pumilio target
by TAP) correlates with low mRNA stability only in
the neural fate mRNA class.
The significant enrichment of PREs among low-
stability neural fate mRNAs suggested a novel role for
Pumilio in neural development. Pumilio has been impli-
cated in the regulation of pre- and post-synaptic morph-
ology and function [36] and memory formation [37] in
Drosophila. We investigated the expression of Pumilio in
Figure 5 Pumilio regulates neural mRNA stability. (A) Enrichment or depletion of candidate cis-regulatory elements as follows: AREs, miR-124
target sites, and PREs. Odds ratios were calculated as the frequency of each element within the low-stability (t1/2 ≤ 75 min) ‘neural fate’ mRNAs
or high-stability (t1/2 ≥ 80 min) ‘localized’ mRNAs versus the frequency of that element in all low-stability or high-stability neural mRNAs.
** = P value < 1.0 × 10−15 (Fisher’s test). (B) Pumilio expression in a stage 15 embryo detected with an anti-Pumilio antibody (green). Anti-Fas2 antibody
stain (magenta) shows a subset of longitudinal axon fiber tracts and axons leaving the ventral nerve cord. (C) Cumulative distribution function plots of
mRNA half-life changes in Pumilio RNAi versus control embryos (Pumilio RNAi/control ratio). The distribution for all neural mRNAs is plotted in blue. The
distribution for predicted Pumilio targets is plotted in red. The shift to the right for predicted Pumilio targets indicates a trend of stabilization in Pumilio
RNAi embryos. The P value is from a Kolmogorov-Smirnoff test comparing the half-life changes (Pumilio RNAi/control) for predicted Pumilio targets and
non-targets. (D) Examples of predicted neural fate Pumilio targets with increased mRNA stability in Pumilio RNAi embryos. These transcripts
had reproducible changes in half-life with FDRs ≤0.30 (based on SAM analysis).
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localization of Pumilio in the cytoplasm of neural pro-
genitors, neurons, and certain axon projections through-
out the ventral nerve cord (Figure 5B), similar to
Pumilio expression patterns in the larval central nervous
system [36].
To test if Pumilio affects neural mRNA decay, we
used neural-specific RNA interference [38] to de-
crease Pumilio expression. Western blot analysis
showed that Pumilio RNAi decreased Pumilio protein
to approximately 50% of wild-type levels (Additional
file 10). Knockdown of Pumilio using pros-Gal4 X
UAS-pumilio{RNAi} did not cause detectable neural
development defects, based on analysis of Fas2+ axon
projection patterns and production of Eve+ neurons.
We conclude that partial knockdown of Pumilio has
no effect or subtle effects on neural development.
However, we predicted that partial knockdown of
Pumilio should be sufficient to induce changes in
mRNA stability if Pumilio regulates mRNA decay.
We performed TU-decay experiments in Pumilio
knockdown embryos, with pros-GAL4 driving UAS-Pumilio{RNAi} and UAS-T.g.UPRT. Neural mRNA half-
lives in the Pumilio knockdown embryos were com-
pared to control pros > UPRT half-lives. Reproducible
half-life measurements were obtained for 3,008 tran-
scripts, and predicted Pumilio targets (PRE-containing
transcripts) showed a significant trend of stabilization
compared to non-targets (Figure 5C, Additional
file 11). Data were obtained for 265 predicted Pumi-
lio targets, and 132 (50%) had a statistically-
significant increase in mRNA half-life of ≥1.3-fold. As
expected, many of the stabilized Pumilio targets encode
transcription factors and other cell-fate determinants
(Figure 5D). Stabilized Pumilio targets also include regu-
lators of axon pathfinding (Eph receptor tyrosine kinase,
off-track, Sema-1a) that are not predicted to localize in
axon growth cones. These experiments did not yield re-
producible data for the one stable Pumilio target pre-
dicted to localize to axon growth cones or dendrites,
Tetraspanin 42Ee. However, we did obtain measurements
for another predicted localized Pumilio target, discs large
1 (dlg1). dlg1 mRNA was previously identified as a target
of translation repression by Pumilio [39], and its
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lian neurons [40]. dlg1 mRNA is relatively unstable in
control embryos (half-life =65 min) and is significantly
stabilized in Pumilio{RNAi} embryos (half-life =127 min).
To test if a 3’ UTR PRE is necessary for destabilization
of a predicted Pumilio target in the nervous system, we
constructed reporter transcripts composed of the hsp70
5’ UTR, the green fluorescent protein (GFP) open read-
ing frame, and one of three 3’ UTR sequences contain-
ing an endogenous transcription termination signal; the
RPS9 3’ UTR (without any PRE), the Hey 3’ UTR
(containing a single naturally occurring PRE), and a Hey
3’ UTR with the PRE deleted (Figure 6A). These reporter
constructs were placed under UAS control and inte-
grated into the same chromosome locus in transgenic fly
lines. Pros-Gal4 was used to activate transcription of the
reporter and UAS-UPRT, thus allowing neural-specific
measurement of reporter stability. The reporter contain-
ing the RPS9 3’ UTR had slightly above average stability,
similar to the endogenous RPS9 transcript (Figure 6B).
In contrast, the reporter containing the Hey 3’ UTR was
rapidly decayed. Deletion of the PRE from the Hey 3’
UTR caused a dramatic increase in stability compared to
the unmodified Hey 3’ UTR reporter. These results agree
with the increased stability of the endogenous Hey tran-
script in Pumilio{RNAi} embryos and the lack of any sig-
nificant change in endogenous RPS9 transcript stabilityFigure 6 PREs increase the rate of transcript decay in the nervous system.
endogenous PRE. Hey PRE Δ 3’ UTR has only the PRE sequence removed
measurements of reporter transcript decay (using GFP primers). Chase tim
chase/pulse values at the 1-hour chase and 3-hour chase time points are
listed next to the decay curve for each transcript.in Pumilio{RNAi} embryos (Additional file 11). We con-
clude that the single PRE within the Hey 3’ UTR targets
this transcript for degradation in the nervous system.
Discussion
mRNA abundance during neural development is deter-
mined by the rate of gene transcription and the rate of
mRNA decay. We addressed the role of mRNA decay in
neural development using the TU-decay technique. Our
results provide in vivo measurements of zygotic mRNA
decay in Drosophila embryos and allow investigation of
neural-specific mRNA decay properties. It is difficult to
determine how closely half-lives calculated by TU-decay
reflect endogenous decay rates, since any technique used
to quantify mRNA turnover may introduce biases. How-
ever, the global trends of mRNA decay identified in this
work are similar to those described for other systems
(for example, gene ontology categories for low-stability
versus high-stability mRNAs), suggesting that TU-decay
provides accurate measurements of relative mRNA
stability.
Our comparison of whole embryo and neural-specific
mRNA decay data revealed unique neural mRNA decay
properties for 893 transcripts. While we have not
checked the expression patterns of all 893 transcripts,
many are expressed in the nervous system and add-
itional tissues. We conclude that the different half-life(A) Reporter construct design. Hey WT 3’ UTR contains the single
. (B) Decay curves based on reverse-transcription, quantitative-PCR
es are plotted on the x-axis (0-hour = end of 1-hour pulse). Mean
plotted based on multiple measurements. Half-lives in minutes are
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neous transcript decay measurements in whole embryo
experiments versus more homogeneous transcript decay
measurements in the neural-specific TU-decay experi-
ments. Neural-specific decay properties likely enable a
single mRNA to have distinct expression dynamics in
the nervous system compared to other tissues.
Many transcripts with decreased stability in the ner-
vous system encode proteins involved in cell growth and
proliferation, such as ribosomal proteins and histones.
This may relate to the transition from proliferation to
differentiation that occurs in the nervous system at the
embryonic stages we analyzed. Early-born neuroblast
progeny differentiate into neurons and glia at stage 12,
and progenitor proliferation significantly decreases by
stage 15 [41]. A similar decrease in proliferation occurs
in yeast shifted to nutrient-limited media, and this tran-
sition causes a dramatic destabilization of ribosomal pro-
tein mRNAs [13]. Lower histone mRNA stability has
been described for human fibroblasts compared to their
corresponding induced pluripotent stem cells (iPSCs)
[42]. Histone mRNAs are more stable in iPSCs, presum-
ably to support chromosome replication and the produc-
tion of differentiated progeny. Similar destabilization of
histone mRNAs in the differentiating embryonic nervous
system may be related to the decreased mitotic potential
of progenitors and the post-mitotic state of neurons.
Many transcripts with increased stability in the ner-
vous system encode proteins with known neural-specific
functions, including neurotransmission, axonogenesis,
and maintenance of neuroblast polarity. Many of these
genes have widespread expression patterns but elevated
levels of mRNA or protein in the nervous system. Exam-
ples include Cadherin-N (CadN), Apc-like (Apc), and
bazooka (baz). CadN is expressed in embryonic muscles
and neurons, but the protein is detected at much higher
levels in neurons [43]. Apc is detected ubiquitously at
low levels in embryos, with high levels of protein con-
centrated in the central nervous system [44]. Bazooka
mRNA is detected in epithelial cells and neuroblasts,
where Bazooka regulates spindle orientation and cell po-
larity [45]. Multiple mRNAs encoding regulators of
neuroblast polarity had increased stability based on
neural-specific measurements as follows: baz, pins,
par-6, Lgl, and Gαo. The stability of these transcripts
may support appropriate levels of protein production in
neuroblasts without the need for high rates of transcrip-
tion. Baz, Par-6, and Lgl also have functions in post-mitotic
neurons [46,47] and the increased stability of these mRNAs
could be due to stabilization in neurons.
Genome-wide studies of mRNA decay in other sys-
tems support a model in which mRNA half-life is linked
to the function of the encoded protein [10,48]. We
found that this model is applicable to mRNAs encodingtranscription factors that regulate neural cell-fate deci-
sions. These transcription factors tend to act transiently
in neural progenitors or their progeny and have precise
spatial or temporal expression patterns. While the ex-
pression of these genes likely involves transcriptional in-
duction and repression, a short mRNA half-life will
ensure robust expression patterns. Many cell-fate deter-
minant transcription factors appear to be transcribed at
low levels and rapidly decayed, since 1-hour pulse mea-
surements yielded weak signals, and we could not detect
any signal above background in subsequent chase mea-
surements. Examples include cell-fate determinants that
are transiently expressed in neural progenitors, such as
gcm [49], ac [50], and Kr [51]. Future work could im-
prove the analysis of weakly transcribed, rapidly
decayed mRNAs by including earlier chase time points
and using more sensitive detection methods (such as
RNA-sequencing).
We also identified a potential relationship between
mRNA half-life and mRNA localization in neurons.
While the predicted localization of candidate mRNAs re-
mains to be confirmed, several of the corresponding
proteins are known to localize to axon terminals or den-
drites in Drosophila. It will be interesting to test if a long
mRNA half-life is predictive of subcellular localization in
neurons, particularly for transcripts whose mammalian
orthologs have not previously been identified in growth
cones or dendrites. For example, Stretchin-Mlck and
Fuseless are among the most stable neural mRNAs,
and their proteins have known roles in axon guidance
[52] and synaptic vesicle exocytosis [53], respectively.
Stretchin-Mlck is predicted to act at axon growth cones,
and Fuseless is concentrated in presynaptic sites of
neuromuscular junctions, but their mRNA localization
and site of translation is unknown.
While the data generated in this study may be useful
for de novo identification of cis-regulatory elements, here
we chose to focus on candidate elements that might
determine the decay rate of neural cell-fate mRNAs.
Pumilio recognition elements were the only significantly
enriched element among this class of mRNAs. Trad-
itional models of Pumilio function emphasize its role as
a negative regulator of translation, but recent work has
shown that Drosophila Pumilio and human orthologs
promote deadenylation that is likely to subsequently
trigger transcript decay [54]. In addition, an mRNA
decay function for Pumilio was predicted based on the
enrichment of PREs in Drosophila maternal mRNAs de-
graded by zygotic factors [10]. In this study, we identi-
fied a novel mRNA decay function for Pumilio during
neural development. We found that an 8-nucleotide PRE
motif defined by Gerber et al. [35] is significantly
enriched among low-stability neural fate mRNAs and is
necessary for decay of a reporter construct. Interestingly,
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identified as Pumilio targets by tandem-affinity purifica-
tion using a TAP-tagged Pumilio fragment [35]. The ab-
sence of these transcripts from the TAP dataset may be
due to differences in experimental design. For example,
the TAP experiments used a maternal GAL4 to drive ex-
pression of TAP-Pumilio ubiquitously in early embryos
while our TU-decay data are neural-specific. These re-
sults may also indicate that Pumilio-dependent mRNA
decay involves co-factors that are neural-specific. The
increased stability of neural fate mRNAs in Pumilio
knockdown embryos supports our model and suggests
that Pumilio influences critical programs of gene expres-
sion during neural development. The regulation of
Pumilio-dependent mRNA decay in the developing
nervous system will be an important area of future
investigation.
Conclusions
TU-decay experiments revealed dynamic regulation of
mRNA stability within the developing nervous system.
These results suggest that differential mRNA decay con-
tributes to the spatiotemporal gene expression patterns
for many important regulators of neural development.
These data provide a useful resource for defining com-
ponents of the neural mRNA decay regulatory network,




The following fly lines were used: UAS-T.g.UPRT (3rd
chromosome), UAS-T.g.UPRT (2nd chromosome, pro-
vided by M. O’Connor), prospero-Gal4, and UAS-
GFP::lacZ.nls (Bloomington Drosophila Stock Center
(BDSC)). Whole embryo TU-decay experiments were
performed using embryos of either UAS-T.g.UPRT line
without any Gal4 driver. Pumilio knockdown was per-
formed using the TRiP project line HMS01685 (BDSC
stock number 38241). UAS-GFP-3’UTR reporter con-
structs were made by modifying pUAST-3XemGFP
(Drosophila Genetics Resource Center) to remove two
copies of emGFP and replace the SV40 terminator with
the Drosophila Hsp70 terminator and an attB site. RPS9,
Hey wild type, and Hey PRE deletion 3’ UTR DNA were
chemically synthesized (Integrated DNA Technologies)
and ligated into the modified pUAST-emGFP-attB back-
bone. Constructs were injected into P{nos-phi-
C31\int.NLS}X, P{CaryP}attP40 embryos for PhiC31-
mediated integration (Rainbow Transgenic Flies, Inc.).
TU-tagging
Stage 12 to 15 embryos were used for pulse-chase label-
ing of RNA. Embryos were permeabilized as previouslydescribed [12] and pulse-labeled in tagging media [D22
insect media, 5% FBS, and either 1 mM 4-thiouridine
(whole embryo tagging) or 1 mM 4-thiouracil (neural-
specific tagging)] for 1 h at 30°C. Pulse-labeled embryos
were then transferred for 1 or 3 h to chase media
containing uridine [D22 insect media, 5% FBS, 10 mM
uridine] at 30°C. Embryos were homogenized for 30 sec
and frozen in Trizol (Invitrogen) at −80°C. Multiple sam-
ples for each time point were pooled for RNA extraction
and TU-RNA purification, as previously described [12].
Microarray analysis
Biological replicates (independent RNA collections, TU-
RNA purifications, and microarray hybridizations) were
performed for all experiments. Purified TU-RNA plus a
spike-in control (One-Color RNA Spike-In Kit, Agilent)
was used to generate Cy3 labeled cRNA (Low Input
Quick Amp Labeling Kit, Agilent) and hybridized to
Agilent 4x44K Drosophila gene expression microarrays.
Signal intensities within a pulse-chase series were nor-
malized using the spike-in control. For comparisons be-
tween pulse-chase series, 1-hour chase/1-hour pulse and
3-hour chase/1-hour pulse ratios were normalized so
that the mean of the ratios at each time-point was the
same across experiments (the top and bottom 10%
ratio values were excluded from normalization factor
calculations). For comparisons of signal intensities in
1-hour pulse samples (Figure 2C), spots with values below
background were excluded from mean normalization
calculations but were included in calculations of average
signal intensity per gene.
Data access
The microarray data were deposited in the NCBI Gene
Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.
gov/geo/) under accession numbers GSE67435 (whole
embryo data) and GSE67512 (neural-specific data).
Statistical analysis
Statistical analyses of genome-wide mRNA levels and
genome-wide half-life values were made using mean-
normalized ratio values for each dataset and absolute
difference calculations using the significance analysis of
microarrays (SAM) program [55]. Two-class, unpaired
sample analysis and the T-statistic were used to calculate
q values (a multiple testing corrected false discovery rate
(FDR)). FDR values listed in figure legends are the q
value (for statistical analyses performed using SAM). All
other statistical analyses were made using the R software
environment. For comparisons of half-life values be-
tween samples (neural-specific versus whole embryo,
Pumilio RNAi versus control), only transcripts with re-
producible measurements across biological replicates
were included. Reproducible measurements were defined
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mean half-life.
mRNA half-life calculations
Normalized signal intensities for time 0, 1, and 3 h were
fitted to the linear transform of a single order exponen-
tial decay model, ln(Ε(t)) = Ε0
kt, by least squares regres-
sion analysis in R. E0 is the transcript expression value
for the pulse-labeled sample and k is the decay rate con-
stant. Fit of the decay model was assessed by an adjusted
R2 value. Half-life was determined by the equation,
t1/2 = ln2/k. Many mRNAs whose levels decreased
slightly or not at all during the chase had R2 ≤ 0.75.
These high-stability mRNAs (typically with half-lives
estimated at ≥300 min) were excluded from calculations
of mean and median half-life for all datasets. mRNAs in
this category that had reproducible half-life measure-
ments across biological replicates (standard deviation/
mean ≤60%) were included as high-stability mRNAs for
gene ontology analyses and comparisons of whole em-
bryo versus neural mRNA half-lives.
Gene ontology analysis
Gene ontology analysis was performed using DAVID
functional annotation clustering [56,57], with default set-
tings and high classification stringency. Unnamed genes
(those identified by CG number only) were excluded
from GO analysis. Representative GO terms for each
annotation cluster are listed in the results tables. Func-
tionally redundant annotation clusters were excluded.
Immunofluorescent imaging and in situ RNA hybridization
Embryo fixation and antibody staining were performed
using standard methods. The following antibodies were
used: rat anti-Pumilio (1:200, provided by Robin Wharton),
mouse anti-Fas2 (1:100, Developmental Studies Hybridoma
Bank), mouse anti-prospero (1:20, Developmental Studies
Hybridoma Bank), rabbit anti-β-gal (1:1000, Abcam). RNA
probes were made using cDNA clones obtained from the
Drosophila Genome Resource Center, Indiana University,
USA. Digested plasmids were used as template for in vitro
transcription of DIG-labeled RNA probes (Roche Applied
Science). In situ hybridization was performed using stand-
ard methods.
Reverse transcriptase quantitative PCR
Purified TU-RNA quality was assessed by Bioanalyzer
RNA Pico Eukaryotic total RNA assay (Agilent) prior to
whole transcriptome amplification and cDNA synthesis
(MessageBOOSTER Whole-TranscriptomecDNA Synthe-
sis Kit for qPCR, Epicentre). Real-time PCR quantitation
was performed on a Rotor-Gene Q (Qiagen) in 20 uL reac-
tions using QuantiTect Primer Assays (Qiagen) or custom
designed primers (table), and SYBR green detection (SYBRSelect Master Mix, Applied Biosystems). Ct values
were normalized to an RpL32 internal reference and
relative abundance calculated by the equation, fold-
change = 2Δ(ΔCt). Transcript decay was modeled as
described above using relative abundance at time 0, 1
and 3 h.
Additional files
Additional file 1: Transcription arrest in actinomycin D treated
embryos. TU-RNA blot for control and ActD-treated embryos.
Additional file 2: Uracil number and transcript abundance do not
bias mRNA decay measurements. Scatter plots of uracil number versus
mRNA half-life (A) and transcript abundance in the 1-hour pulse sample
versus mRNA half-life (B).
Additional file 3: Gene ontology categories of low-stability and
high-stability mRNAs from UO and U + actD experiments. Table
listing the gene ontology category enrichment for the 1,000 least stable
and 1,000 most stable mRNAs in each dataset.
Additional file 4: Whole embryo mRNA 1-hour pulse expression
levels and transcript half-lives. Table listing normalized 1-hour pulse
(t0) microarray signal intensity and normalized transcript half-life. Values
are the mean per transcript calculated by combining the UO and U + actD
experiments. Standard deviation (SD) is listed for the 1-hour pulse and
half-life values.
Additional file 5: Neural-enriched mRNAs identified by Pros > UPRT
TU-tagging. Table listing log2 ratio of normalized microarray signals for
TU-RNA purified from Pros > UPRT embryos divided by untagged RNA
signals from the same embryos (pros UPRT log2 4TU/untag). Tissue
expression pattern is summarized for all mRNA with log2 value >0.52
in the ‘Expression’ column, and the evidence for the tissue expression
is referenced in the ‘Source’ column. BDGP = Berkeley Drosophila
Genome Project in situ hybridization database.
Additional file 6: Neural-specific mRNA 1-hour pulse expression
levels and transcript half-lives. Table listing normalized 1-hour pulse
(t0) microarray signal intensity and normalized transcript half-life for
neural-specific measurements. Values are the mean per transcript
calculated by combining duplicate Pros > UPRT TU-Decay experiments.
Standard deviation (SD) is listed for the 1-hour pulse and half-life values.
Additional file 7: Neural versus whole embryo half-lives. Table
listing neural-specific and whole embryo half-lives and the ratio of
neural/whole embryo half-life. The statistical significance of half-life
differences was assessed by SAM analysis, and the q value (false discovery
rate) is listed for each transcript (ns = not significant).
Additional file 8: Half-life of neural fate and localized mRNAs. Table
listing 1-hour pulse (t0) and half-life for the ‘neural fate’ and ‘localized’
categories of mRNAs. Transcripts that contain a PRE motif in the 3’ UTR
are noted in the ‘Contains PRE’ column.
Additional file 9: There is no correlation between 3’ UTR length
and mRNA half-life. Scatter plot comparing 3’ UTR length and mRNA
half-life for whole embryo and neural-specific datasets.
Additional file 10: Decreased Pumilio expression in Pumilio RNAi
embryos. Anti-Pumilio western blot of control and Pumilio RNAi embryos.
Additional file 11: Pumilio RNAi versus control half-lives. Table
listing Pumilio RNAi half-lives (average per transcript across three replicate
experiments) and control half-lives (average per transcript across two
replicate experiments) and the ratio of Pumilio RNAi/control half-life.
The statistical significance of half-life differences was assessed by SAM
analysis and the q value (false discovery rate) is listed for each transcript
(ns = not significant).
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